NI
National Institutes of Health
AcceleratorActiveNational Institutes of Health is a biomedical research facility in the United States that focuses on biomedical and health-related research.
413
Investments
36
Exits
—
AUM
8.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for National Institutes of Health.
Investment Thesis & Strategy
NIH invests in various stages of biotech, fintech, health diagnostics, advertising/marketing, and healthcare companies, with a focus on biomedical and health-related research.
Investment Activity
Deals per year over the last 6 years
4
20184
20191
20202
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 413 companies
O
Obsidio
Biotech · Series A, 2023
T
TScan Therapeutics
Biotech · Series B, 2021
V
Ventyx Biosciences
Biotech · Series B, 2021
V
Vaxart
Biotech · Growth, 2020
C
Cabaletta Bio
Biotech · Series B, 2019
C
Century Therapeutics
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2019
L
Lyell Immunopharma
Biotech · Series B, 2019
A
Aura Biosciences
Biotech · Series B, 2018
C
Cerevance
Biotech · Series B, 2018
G
Gossamer Bio
Biotech · Series B, 2018
R
Revolution Medicines
Biotech · Series B, 2018
Frequently Asked Questions
National Institutes of Health focuses on Pre-seed, Seed stage investments.